Adam MD - Zealand Pharma Pres CEO
| ZEAL Stock | DKK 622.00 23.00 3.84% |
Insider
Adam MD is Pres CEO of Zealand Pharma AS
| Age | 49 |
| Phone | 45 88 77 36 00 |
| Web | https://www.zealandpharma.com |
Zealand Pharma Management Efficiency
The company has return on total asset (ROA) of (0.4816) % which means that it has lost $0.4816 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4412) %, meaning that it generated substantial loss on money invested by shareholders. Zealand Pharma's management efficiency ratios could be used to measure how well Zealand Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Mikkel Wagner | Ambu AS | N/A | |
| Jorgen Moeller | DSV Panalpina AS | 70 | |
| Roland Andersen | FLSmidth Co | 55 | |
| Michael Ebbe | DSV Panalpina AS | 53 | |
| Thomas Henriksen | Ambu AS | 50 | |
| Gunther Pausch | GN Store Nord | N/A | |
| Mns Barsne | Ambu AS | N/A | |
| Brian Pedersen | GN Store Nord | N/A | |
| Henrik MSc | Bavarian Nordic | 58 | |
| Jannick Denholt | FLSmidth Co | N/A | |
| Britt Jensen | Ambu AS | 50 | |
| Nicolai Thomsen | Ambu AS | N/A | |
| Mikko Keto | FLSmidth Co | 56 | |
| Anne Veyhe | GN Store Nord | N/A | |
| Rolf Srensen | Bavarian Nordic | N/A | |
| Aurangzeb Khan | GN Store Nord | N/A | |
| Peter Gormsen | GN Store Nord | 49 | |
| Annette Terndrup | FLSmidth Co | 54 | |
| Sofie Lindberg | FLSmidth Co | N/A | |
| Mette MEng | FLSmidth Co | 56 | |
| Cori Petersen | FLSmidth Co | 54 | |
Management Performance
| Return On Equity | -1.44 | |||
| Return On Asset | -0.48 |
Zealand Pharma AS Leadership Team
Elected by the shareholders, the Zealand Pharma's board of directors comprises two types of representatives: Zealand Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zealand. The board's role is to monitor Zealand Pharma's management team and ensure that shareholders' interests are well served. Zealand Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zealand Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Henriette Wennicke, Chief Officer | ||
| Lani Morvan, Investor Officer | ||
| Adam MD, Pres CEO | ||
| Hanne Bak, RD Director | ||
| Mads Kronborg, Head Communication | ||
| Ravinder Chahil, Sr Counsel | ||
| Christina Bredal, VP Organization | ||
| Danilo Verge, Head Affairs | ||
| Ivan Moller, Chief Officer | ||
| Jens MD, Head Pharmacology |
Zealand Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zealand Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.44 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (3.82) % | |||
| Current Valuation | 10.33 B | |||
| Shares Outstanding | 51.28 M | |||
| Shares Owned By Insiders | 0.07 % | |||
| Shares Owned By Institutions | 56.21 % | |||
| Price To Earning | 12.66 X | |||
| Price To Book | 27.77 X | |||
| Price To Sales | 36.73 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zealand Pharma AS. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Zealand Stock analysis
When running Zealand Pharma's price analysis, check to measure Zealand Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zealand Pharma is operating at the current time. Most of Zealand Pharma's value examination focuses on studying past and present price action to predict the probability of Zealand Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zealand Pharma's price. Additionally, you may evaluate how the addition of Zealand Pharma to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |